摘要
腹膜平衡试验对于判断腹膜溶质转运功能非常重要,影响它的因素很多,营养和腹膜炎是较突出的问题,国内有关此方面的研究尚少,我们着重研究白蛋白与腹膜平衡试验的关系及腹膜炎恢复期时腹膜功能的变化。 一、材料及方法 1.
出处
《中华肾脏病杂志》
CAS
CSCD
北大核心
1997年第5期303-304,共2页
Chinese Journal of Nephrology
同被引文献11
-
1[1]Churchill DN, Taylor DW, Keshaviah PR, et al. Adequacy of dialysis and nutrition in continuous peritoneal dialysis association with clinical outcomes. J Am Soc Nephrol, 1996,7:198 - 207
-
2[2]Bachmann J, Tepel M, Raidt H, et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol, 1995,6:121 - 125
-
3[3]Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in endstage renal disease. Circulation, 1998,97:138- 141
-
4[4]Vychytil A, Fodinger M, Papagiannopoulos M, et al . Peritoneal elimination of momocysteine moieties in continuous ambulatory peritoneal dialysis patients. Kidney Int, 1999,55:2054-2061
-
5[5]Ducloux D, Heuze- lecornu L, Gibey R, et al. Dialysis adequacy and homocyst(e)inc concentrations in peritoneal dialysis patients.Nephrol Dial Transplant, 1999,14:728- 731
-
6[6]Bostom AG, Shemin D, Lapane KL, et al. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis, 1996,123:193 - 202
-
7[7]De vecchi AF, Bamonti- Catena F, Finzzzi S, et al. Homocysteine,vitamin B12, and serum and erythrocyte in peritoneal dialysis and hemodialysis patients. Perit Dial Int, 2000,20:169- 173
-
8[8]Vychytil A, Fodinger M, Wolff G, et al. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Kidney Int,1998,53:1775 - 1782
-
9[9]Moustapha A, Gupta A, Robinson K, et al. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int, 1999,55:1470-1475
-
10[10]Heltberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol, 1993,40:230- 234
-
1郑丹侠,范敏华,韩庆烽.71例腹透患者的腹膜平衡试验分析[J].临床荟萃,1998,13(24):1107-1108. 被引量：1
-
2陈瑛.糖尿病肾病致慢性肾衰竭腹膜透析患者腹膜平衡试验特点[J].中国医药导刊,2009,11(1):26-26.
-
3陈志勇,常平,周伟东,李向阳,杨芳,周兰珍.糖尿病肾病尿毒症患者腹膜平衡试验及其临床意义[J].肾脏病与透析肾移植杂志,1998,7(6):534-537. 被引量：1
-
4钟慧,苏白海,邱红渝,沙朝晖,刘芳,唐晓红,包芸,付平.不同腹膜转运特性的腹膜透析患者炎症和氧化应激状态的研究[J].中国实用内科杂志,2007,27(11):860-862. 被引量：4
-
5潘玲,黎伟,廖蕴华.持续非卧床腹膜透析患者低钾血症的影响因素及相关性分析[J].广西医学,2014,36(2):204-206. 被引量：6
-
6武煜,王玲,张曙光,孙浩远,张林.86例腹膜透析治疗慢性肾功能不全的临床体会[J].齐齐哈尔医学院学报,2009,30(23):2918-2918. 被引量：2
-
7胡伟平,张燕林.三七总皂苷对腹膜纤维化大鼠转化生长因子-β_1的影响[J].中国中西医结合肾病杂志,2014,15(12):1100-1102. 被引量：15
-
8袁静,贾汝汉,李华,杨定平,邵进.持续不卧床腹膜透析充分与否对降压疗效的影响[J].湖北医科大学学报,1998,19(1):40-41.
-
9庄福春,刘建社,朱忠华,邓安国,袁海,黄杰.姜黄素对大鼠腹膜纤维化的作用及其对BMP-7、TGF-β1，表达的影响[J].临床肾脏病杂志,2008,8(9):416-418. 被引量：1
-
10王俊坦.腹膜转运特性与糖尿病肾病腹膜透析患者预后的关系[J].现代仪器与医疗,2016,22(4):114-115. 被引量：6
